[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353803-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353803-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multi-omics-analysis-and-experiments-validate-the-tumor-suppressive-role-of-mitochondrial-lipid-metabolism-gene-acsm5-in-lung-adenocarcinoma-and-its-impact-on-the-immune-microenvironment","Multi-omics analysis and experiments validate the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the immune microenvironment","","Lung adenocarcinoma (LUAD) is a common non-small cell lung cancer with high incidence and poor outcomes. Mitochondrial lipid metabolism (MTLM) supports tumor growth and drug resistance, yet its role in LUAD remains unclear. A four-gene MTLM prognostic model was built from MTLM genes and validated across TCGA and GEO datasets, including nomograms, immune microenvironment assessment, drug-sensitivity evaluation, and ceRNA/TF network construction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multi-omics-analysis-and-experiments-validate-the-tumor-suppressive-role-of-mitochondrial-lipid-metabolism-gene-acsm5-in-lung-adenocarcinoma-and-its-impact-on-the-immune-microenvironment/353803/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multi-omics-analysis-and-experiments-validate-the-tumor-suppressive-role-of-mitochondrial-lipid-metabolism-gene-acsm5-in-lung-adenocarcinoma-and-its-impact-on-the-immune-microenvironment/353803.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main objective in LUAD?","Question",{"text":63,"@type":64},"To validate the tumor-suppressive role of the mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and determine its impact on the immune microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were prognostic genes and the four-gene model constructed and validated?",{"text":68,"@type":64},"MTLM-associated genes were extracted from MitoCarta 3.0 and publications, then a four-gene Cox prognostic model was created. The model was verified using TCGA and GEO datasets and supported by a clinical-feature nomogram.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about ACSM5 and patient prognosis?",{"text":72,"@type":64},"A MTLM-related model using ACSL4, ACSS3, CHPT1, and ACSM5 was established, with ACSM5 contributing most. High-risk patients had shorter survival, and ACSM5 was linked to better prognosis and acted as an independent prognostic factor.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353803,1790381118,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":30,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Wu et al. Human Genomics (2026) 20:47 Human Genomics  \n[https://doi.org/10.1186/s40246-026-00916-z](https://doi.org/10.1186/s40246-026-00916-z)  \nRESEARCH Open Access  \nMulti-omics analysis and experiments validate  the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the  \nimmune microenvironment  \nSixuan Wu1, Bowen Tang1, Wujie Wei2* and Yuehua Li 1*  \nAbstract  \nBackground Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer, characterized by high incidence and poor prognosis. Mitochondrial lipid metabolism (MTLM) contributes to tumor proliferation and drug resistance by regulating lipid breakdown and energy supply and is strongly linked to prognosis in multiple cancers. Nevertheless, its impact on LUAD has yet to be clarified.  \nMethods MTLM-associated genes were extracted from the MitoCarta 3.0 database and relevant publications. A four-gene prognostic model was formulated using Cox regression analysis, with individual gene contributions clarified through Shapley Additive Explanations (SHAP) analysis. The model was verified using The Cancer Genome Atlas and Gene Expression Omnibus datasets, and a nomogram incorporating clinical features was developed. Immunomicroenvironment characteristics and drug sensitivity were evaluated, leading to the identification of potential therapeutic agents. A competing endogenous RNAs (ceRNA) and transcription factor (TF) regulatory network was constructed for the core genes. Drug components targeting these core genes were identified through reverse pharmacology and molecular docking. Single-cell RNA sequencing (scRNA-seq) was carried out to analyze the expression of core genes across cellular subpopulations. Finally, the core gene ACSM5 was investigated for its prognostic value and immune regulatory role in LUAD, with its function further validated through clonogenic assaysand Transwell experiments.  \nResults A MTLM-related prognostic model incorporating ACSL4, ACSS3, CHPT1, and ACSM5 was established, with ACSM5 contributing most significantly to the model’s prediction. Patients in the high-risk group had notably shorter survival than those in the low-risk group, and the risk score was identified as an independent prognostic factor. The nomogram, combining clinical features and risk scores, showed an AUC value of 0.712. Notable differences  \n*Correspondence:  \nWujie Wei [weiwujie1982@163.com](weiwujie1982@163.com)[ ](weiwujie1982@163.com)Yuehua Li[liyuehua2020@stu. usc.edu.cn](liyuehua2020@stu. usc.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nWu et al. Human Genomics (2026) 20:47 Page 2 of 21  \nwere detected between distinct risk groups in terms of immune microenvironment and drug sensitivity. The ceRNA network and TF regulatory network ","cbCaiuURYGKPmW04","https://ap.wps.com/l/cbCaiuURYGKPmW04","pdf",9098354,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What was the study’s main objective in LUAD?\",\"answer\":\"To validate the tumor-suppressive role of the mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and determine its impact on the immune microenvironment.\"},{\"question\":\"How were prognostic genes and the four-gene model constructed and validated?\",\"answer\":\"MTLM-associated genes were extracted from MitoCarta 3.0 and publications, then a four-gene Cox prognostic model was created. The model was verified using TCGA and GEO datasets and supported by a clinical-feature nomogram.\"},{\"question\":\"What did the results show about ACSM5 and patient prognosis?\",\"answer\":\"A MTLM-related model using ACSL4, ACSS3, CHPT1, and ACSM5 was established, with ACSM5 contributing most. High-risk patients had shorter survival, and ACSM5 was linked to better prognosis and acted as an independent prognostic factor.\"}]","Multi-omics analysis and experiments validate the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the immune microenvironment | PDF",1790107337,53,[147,151,155],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/3a55cc9beb7e3912af77f56500c126df.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/d44f9cdbb51b3940ff97538a17b5362c.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/3f80ccbc1450e12a2e0f3c479550da04.webp",981,1308]